Kensico Capital Management Corp Heron Therapeutics, Inc. Transaction History

Kensico Capital Management Corp

  • $3.63 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$14.61 - $22.14 $7.92 Million - $12 Million
-542,100 Closed
0 $0
Q3 2020

Nov 16, 2020
SELL
$13.67 - $17.77 $313,043 - $406,933
-22,900 Reduced 4.05%
542,100 $8.03 Million
Q2 2020

Aug 14, 2020
BUY
$10.89 - $21.47 $6.15 Million - $12.1 Million
565,000 New
565,000 $8.31 Million

Others Institutions Holding HRTX

# of Institutions
179
Shares Held
121M
Call Options Held
80.4K
Put Options Held
94.9K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $188M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Kensico Capital Management Corp Portfolio

Follow Kensico Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kensico Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Kensico Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email